Marinus Pharma CS (MRNS)
0.5500 +0.0005 (+0.09%) 02/11/25 [NASDAQ]
N/A x N/A N/A x N/A
Realtime by (Cboe BZX)
N/A x N/A N/A x N/A
Realtime - - (-) -
for Mon, Feb 10th, 2025
Results
download Want to compare other data? Select FieldsSymbol | MRNS | SRZN | NRXP | ||
Company | Marinus Pharma CS | Consonance-Hfw Acq Corp | Nrx Pharmaceuticals Inc | ||
Price Information | |||||
Exchange | NASDAQ | NASDAQ | NASDAQ | ||
Open | 0.5500 | 9.98 | 1.7000 | ||
High | 0.5500 | 10.22 | 1.7200 | ||
Low | 0.5489 | 8.84 | 1.6300 | ||
Last | 0.5500 | 9.37 | 1.7200 | ||
Change | +0.0005 | +0.02 | +0.0100 | ||
% Change | +0.09% | +0.21% | +0.58% | ||
Volume | 1,102,700 | 8,132 | 40,966 | ||
20-Day Average Volume | 1,233,208 | 13,889 | 193,022 | ||
Previous Close | 0.5495 | 9.35 | 1.7100 | ||
Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
Has Options | No | No | Yes | ||
Technicals | |||||
20-Day Moving Average | 0.5444 | 11.15 | 2.0055 | ||
20-Day Raw Stochastic | 95.50% | 0.00% | 12.05% | ||
20-Day Relative Strength | 58.59% | 38.69% | 37.49% | ||
Weighted Alpha | -40.09 | -31.34 | -80.26 | ||
Today's Opinion | 40% Sell | 24% Sell | 40% Sell | ||
Previous Opinion | 40% Sell | 8% Buy | 40% Sell | ||
Last Month's Opinion | 40% Sell | 56% Buy | 8% Buy | ||
Performance | |||||
5-Days | |||||
%Chg | +0.46% since 02/04/25 | -25.51% since 04/02/25 | -16.42% since 04/02/25 | ||
Low | 0.5450 on 02/05/25 | 8.84 on 04/09/25 | 1.5800 on 04/07/25 | ||
High | 0.5500 on 02/10/25 | 12.26 on 04/03/25 | 2.0000 on 04/07/25 | ||
1-Month | |||||
%Chg | +2.25% since 01/10/25 | -25.95% since 03/07/25 | -22.58% since 03/07/25 | ||
Low | 0.5300 on 01/21/25 | 8.84 on 04/09/25 | 1.5800 on 04/07/25 | ||
High | 0.5560 on 01/13/25 | 14.00 on 03/24/25 | 2.4100 on 03/17/25 | ||
3-Month | |||||
%Chg | +64.06% since 11/11/24 | -31.03% since 01/08/25 | -55.32% since 01/08/25 | ||
Low | 0.2202 on 12/23/24 | 8.84 on 04/09/25 | 1.5800 on 04/07/25 | ||
High | 0.5560 on 01/13/25 | 14.00 on 03/24/25 | 6.0100 on 01/13/25 | ||
6-Month | |||||
%Chg | -54.99% since 08/09/24 | -25.19% since 10/09/24 | +14.29% since 10/09/24 | ||
Low | 0.2202 on 12/23/24 | 8.10 on 11/19/24 | 1.1000 on 10/16/24 | ||
High | 1.9700 on 09/24/24 | 18.17 on 01/03/25 | 6.0100 on 01/13/25 | ||
Key Statistics | |||||
Market Capitalization, $K | 30,370 | 30,386 | 28,926 | ||
Shares Outstanding, K | 55,218 | 3,250 | 16,916 | ||
Annual Sales | 30,990,000 | 10,660,000 | 0 | ||
Annual Net Income | -141,410,000 | -63,560,000 | -25,130,000 | ||
Last Quarter Sales | 8,540,000 | 650,000 | 0 | ||
Last Quarter Net Income | -24,230,000 | -28,040,000 | -9,080,000 | ||
60-Month Beta | 1.03 | 0.69 | 1.41 | ||
Per-Share Information | |||||
Most Recent Earnings | -0.42 on 11/12/24 | -9.10 on 03/31/25 | -0.30 on 03/14/25 | ||
Latest Earnings Date | 03/04/25 | 05/14/25 | 05/13/25 | ||
Most Recent Dividend | N/A | N/A | N/A | ||
Next Ex-Dividends Date | N/A | N/A | N/A | ||
Ratios | |||||
Price/Earnings ttm | 0.00 | 0.00 | 0.00 |